LifeStance Health Group (NASDAQ:LFST) Rating Lowered to “Hold” at Wall Street Zen

LifeStance Health Group (NASDAQ:LFST) was downgraded by investment analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a note issued to investors on Saturday.

Several other brokerages have also recently issued reports on LFST. Zacks Research raised LifeStance Health Group from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, October 7th. BTIG Research started coverage on LifeStance Health Group in a research note on Friday, July 25th. They issued a “buy” rating and a $8.00 price objective on the stock. UBS Group raised their price objective on LifeStance Health Group from $8.50 to $9.00 and gave the stock a “buy” rating in a research note on Friday, August 8th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of LifeStance Health Group in a research note on Wednesday, October 8th. Two analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating and two have given a Sell rating to the company. According to MarketBeat.com, LifeStance Health Group presently has an average rating of “Moderate Buy” and an average price target of $8.50.

LifeStance Health Group Trading Down 5.8%

Shares of NASDAQ:LFST opened at $5.05 on Friday. The stock has a market capitalization of $1.96 billion, a price-to-earnings ratio of -101.00 and a beta of 1.17. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.48 and a current ratio of 1.48. The stock’s 50-day simple moving average is $5.23 and its two-hundred day simple moving average is $5.47. LifeStance Health Group has a 52-week low of $3.74 and a 52-week high of $8.61.

LifeStance Health Group (NASDAQ:LFST) last announced its earnings results on Thursday, August 7th. The company reported ($0.01) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.03) by $0.02. The business had revenue of $345.31 million for the quarter, compared to analysts’ expectations of $345.05 million. LifeStance Health Group had a negative return on equity of 1.11% and a negative net margin of 1.23%.The business’s revenue for the quarter was up 10.6% on a year-over-year basis. During the same period last year, the firm posted ($0.06) earnings per share. LifeStance Health Group has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. Analysts expect that LifeStance Health Group will post -0.18 EPS for the current year.

Insider Activity at LifeStance Health Group

In related news, major shareholder Silversmith Partners I. Gp, Llc sold 3,592,357 shares of LifeStance Health Group stock in a transaction that occurred on Monday, August 18th. The stock was sold at an average price of $5.07, for a total transaction of $18,213,249.99. Following the sale, the insider owned 14,324,197 shares of the company’s stock, valued at approximately $72,623,678.79. This trade represents a 20.05% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, major shareholder Summit Partners L. P sold 8,407,643 shares of LifeStance Health Group stock in a transaction that occurred on Monday, August 18th. The shares were sold at an average price of $5.07, for a total value of $42,626,750.01. Following the sale, the insider directly owned 33,524,715 shares in the company, valued at $169,970,305.05. This trade represents a 20.05% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 20,407,643 shares of company stock valued at $103,466,750. 6.60% of the stock is owned by company insiders.

Institutional Trading of LifeStance Health Group

Several institutional investors and hedge funds have recently added to or reduced their stakes in LFST. DekaBank Deutsche Girozentrale bought a new stake in LifeStance Health Group during the 1st quarter valued at approximately $31,000. Park Edge Advisors LLC bought a new stake in LifeStance Health Group during the 2nd quarter valued at approximately $52,000. Bayesian Capital Management LP bought a new stake in LifeStance Health Group during the 2nd quarter valued at approximately $52,000. Xponance Inc. bought a new stake in LifeStance Health Group during the 1st quarter valued at approximately $69,000. Finally, Public Employees Retirement System of Ohio bought a new stake in LifeStance Health Group in the 2nd quarter worth approximately $70,000. Institutional investors own 85.50% of the company’s stock.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.